I agree, Chris, and tell the other posters who keep referring to my contracted role from 3 years ago, as though I am still on a "payroll'. Those legitimate issues became more legitimate after the ASX failed to find any other issues. The ASX had already approved the company to relist without the added Directors before the investigation. You guys focus on the past so I can only respond as a shareholder to those comments.
We can both agree that everyone should now move on.
- Forums
- ASX - By Stock
- CGB
- Ann: Preliminary Final Report
Ann: Preliminary Final Report, page-67
-
- There are more pages in this discussion • 92 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online